Gurugram-based Wingreens Farms has shifted focus to offline channels to improve unit economics. Its FY23 expenses grew faster than revenue, primarily due to higher cost of goods sold and marketing costs. Wingreens Farms is in the process of raising $10 million at a valuation of $205 million. The company aims to consolidate acquisitions and achieve profitability on the Ebitda level.
Gurugram-based Wingreens Farms has shifted focus to offline channels to improve unit economics. Its FY23 expenses grew faster than revenue, primarily due to higher cost of goods sold and marketing costs. Wingreens Farms is in the process of raising $10 million at a valuation of $205 million. The company aims to consolidate acquisitions and achieve profitability on the Ebitda level.
The topmost cost heads at the firm during the year were purchases of stock in trade and employee-related expenses. The former went up 18.5% to Rs 1,085.6 crore while the latter grew 51.6% to Rs 246.8 crore.
Biopharmaceutical company, PTC Therapeutics, Inc. (PTCT) Monday announced that it expects revenue for full year 2023 to be higher than analysts estimate. Also, it announced outlook for fiscal year 2024.
Total expenses for Cashfree more than doubled to Rs 750 crore during the year, mainly on account of employee costs jumping to Rs 198 crore from Rs 96 crore in the previous fiscal.